Original Research
Published on 09 Jun 2022
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study
in Vaccines and Molecular Therapeutics
- 6,500 views
- 20 citations












